About cookies

Cookies help us improve our online service and improve its content and accessibility. Some cookies are necessary for the pages to work properly. You can accept all cookies or only those that are necessary. You can change the settings by clicking Cookie settings.

Cookie settings

Cookie settings

With the help of cookies, we develop our online service and improve its content and accessibility. Some cookies are necessary for the functionality of the pages.

You can enable the cookies you want by checking the boxes below. After making your selections, click Save and Close. The online service works even if you do not allow any necessary cookies. However, some differences may occur.

The necessary cookies are automatically stored on your browser when you use our web service. These cookies are used to ensure that the fimea.fi web service functions as intended.

The web analytics tool Snoobi helps us understand how our customers use the fimea.fi web service and where they come from.

We use the Siteimprove service to monitor the accessibility of pages, the functionality of links and the finding of pages on search engines.

Skip to Content
fimea.fi front page fimea.fi front page

SearchBar

Select search type
Move to advanced medicine search
Suomi
Svenska
EN
Contact Information
fimea.fi front page fimea.fi front page
Suomi
Svenska
EN
  •   For public
  •   Current events
  •   Databases and registers
  •   Development and HTA
  •   Marketing authorisations
  •   Medical devices
  •   Pharmaceutical safety and information
  •   Pharmacies
  •   Supervision
  •   Veterinary
  •   About us
    • Contact us
    • Open positions
    • Forms
    • Organisation
    • Publications
    • Fees
    • Estimated processing times
    • Data requests
    • Data access authorisations
    • Open data
    • Frequently asked questions
      • Clinical drug trials
      • Generic medicines
      • Invoicing
      • Marketing authorisations
        • Summary of Product Characteristics is to be available also in Swedish
      • Narcotics control
      • New EudraVigilance -system
  • Front page
  • About us
  • Frequently asked questions
  • Marketing authorisations

Marketing authorisations

Suomeksi På svenska

Frequently asked questions

  • Brexit
  • Composition
  • Fees
  • Marketing authorisations
  • Package sizes
  • Perforated blisters
  • Product information
  • Therapeutic indication
  • Transferring marketing authorisation
  • Variation applications
Page 1
1
Previous
Previous
Next
Next
RSS (Opens New Window)(Opens New Window)

Marketing auth FAQ links

  • Summary of Product Characteristics should be available also in Swedish
Print

Site information

  • About us

Quicklinks

  • Whats new
  • Contact
  • Contact information

Follow us

  • Linkedin Linkedin

Home fimea.fi Home fimea.fi